Yayın:
The expression frequency of common fragile sites and genetic predisposition to colon cancer

dc.contributor.buuauthorTunca, Berrin
dc.contributor.buuauthorEgeli, Ünal
dc.contributor.buuauthorZorluoğlu, Abdullah
dc.contributor.buuauthorYılmazlar, Tuncay
dc.contributor.buuauthorYerci, Ömer
dc.contributor.buuauthorKızıl, Ayhan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPatoloji Ana Bilim Dalı
dc.contributor.departmentTıbbi Biyoloji Ana Bilim Dalı
dc.contributor.departmentCerrahi Ana Bilim Dalı
dc.contributor.orcid0000-0002-1619-6680
dc.contributor.researcheridABI-6078-2020
dc.date.accessioned2021-09-08T06:54:38Z
dc.date.available2021-09-08T06:54:38Z
dc.date.issued2000
dc.description.abstractThe expression frequency of common fragile sites induced by aphidicolin (Apc), bromodeoxyuridine (BrdU), and caffeine was evaluated on prometaphase chromosomes obtained from the peripheral blood lymphocytes of 32 patients with colon cancer, 30 of their clinically healthy family members and 30 age-matched normal controls. The proportion of-damaged cells (P < 0.001), the mean number of chromosomal aberrations and the expression frequencies of fragile sites were significantly higher in the patient and relative groups compared to the control group. Our findings show an increased genetic instability in patients with colon cancer and their first-degree relatives. In addition, common fragile sites can be used as a suitable marker for determining genetic predisposition to cancer.
dc.identifier.citationTunca, B. vd. (2000). "The expression frequency of common fragile sites and genetic predisposition to colon cancer". Cancer Genetics and Cytogenetics, 119(2), 139-145.
dc.identifier.doi10.1016/S0165-4608(99)00228-9
dc.identifier.endpage145
dc.identifier.issn0165-4608
dc.identifier.issue2
dc.identifier.pubmed10867150
dc.identifier.scopus2-s2.0-0034043323
dc.identifier.startpage139
dc.identifier.urihttps://doi.org/10.1016/S0165-4608(99)00228-9
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0165460899002289
dc.identifier.urihttp://hdl.handle.net/11452/21759
dc.identifier.volume119
dc.identifier.wos000087783800010
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier Science
dc.relation.journalCancer Genetics and Cytogenetics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectGenetics & heredity
dc.subjectCell lung-cancer
dc.subjectShort arm
dc.subjectBreast-cancer
dc.subjectChromosome breakpoints
dc.subjectColorectal-cancer
dc.subjectFhit gene
dc.subjectHeterozygosity
dc.subjectLymphocytes
dc.subjectAphidicolin
dc.subjectAssociation
dc.subject.scopusWW Domain Containing Oxidoreductase; Spinocerebellar Ataxia 12; Chromosome Fragile Sites
dc.subject.wosOncology
dc.subject.wosGenetics & heredity
dc.titleThe expression frequency of common fragile sites and genetic predisposition to colon cancer
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Tıbbi Biyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Cerrahi Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Patoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama